Copertina

Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Lin‐Zhu Zhang, Xu He, Hai‐Dong Zhu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	MedComm
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy
di: Yu Wu, et al.
Pubblicazione: (2024)

Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
di: Shiqi Li, et al.
Pubblicazione: (2024)

Targeting intracellular cancer proteins with tumor‐microenvironment‐responsive bispecific nanobody‐PROTACs for enhanced therapeutic efficacy
di: Changping Deng, et al.
Pubblicazione: (2025)

Targets of tumor microenvironment for potential drug development
di: Ling Zhang, et al.
Pubblicazione: (2024)

Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer
di: Yunfang Yu, et al.
Pubblicazione: (2024)

Natural killer cells in cancer immunotherapy
di: DanRu Wang, et al.
Pubblicazione: (2024)

New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
di: Sha Qin, et al.
Pubblicazione: (2024)

The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer
di: Yalun Li, et al.
Pubblicazione: (2024)

Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
di: Junshu Li, et al.
Pubblicazione: (2024)

Single‐cell transcriptomics reveals IRF7 regulation of the tumor microenvironment in isocitrate dehydrogenase wild‐type glioma
di: Jinwei Li, et al.
Pubblicazione: (2024)

Exosomes: a double‐edged sword in cancer immunotherapy
di: Jiayi Chen, et al.
Pubblicazione: (2025)

Little ones can do big things: Small molecule inhibitors target PTPN2/PTPN1 for tumor immunotherapy
di: Junyu Wang, et al.
Pubblicazione: (2024)

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
di: Xiaoting Luo, et al.
Pubblicazione: (2024)

Patient‐derived ovarian cancer organoid carries immune microenvironment and blood vessel keeping high response to cisplatin
di: Yuqing Zhao, et al.
Pubblicazione: (2024)

Liposome‐based in situ antigen‐modification strategy for “universal” T‐cell‐receptor engineered T cell in cancer immunotherapy
di: Qin Wang, et al.
Pubblicazione: (2024)

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
di: Zheng Liu, et al.
Pubblicazione: (2025)

Perioperative immunotherapy: the main clinical treatment for resectable non‐small cell lung cancer
di: Zhijun Yuan, et al.
Pubblicazione: (2024)

Fc‐null anti‐CTLA‐4 antibody: a novel strategy to facilitate cancer immunotherapy by ridding the colitis‐inducing mishap
di: Jingjing Chen, et al.
Pubblicazione: (2024)

Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1
di: Yalei Wen, et al.
Pubblicazione: (2025)

PGE2‐EP2/EP4 axis: A new perspective on cancer immunotherapy
di: Lin Chen, et al.
Pubblicazione: (2024)

Penfluridol inhibits melanoma growth and metastasis through enhancing von Hippel‒Lindau tumor suppressor‐mediated cancerous inhibitor of protein phosphatase 2A (CIP2A) degradation
di: Fuyan Xu, et al.
Pubblicazione: (2024)

Cancer‐Associated Fibroblasts: Origin, Classification, Tumorigenicity, and Targeting for Cancer Therapy
di: Chang Fan, et al.
Pubblicazione: (2025)

Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy
di: Fei Wang, et al.
Pubblicazione: (2024)

Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
di: Fang‐Zheng Qi, et al.
Pubblicazione: (2024)

Targeting the DNA damage response in cancer
di: Federica Guffanti, et al.
Pubblicazione: (2024)

Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges
di: Jie Xu, et al.
Pubblicazione: (2024)

Crizotinib: A Novel Strategy to Reverse Immunosuppression in Melanoma by Targeting Lactate Transport
di: Zhe Zhou, et al.
Pubblicazione: (2025)

Tyrosine phosphatase SHP2 aggravates tumor progression and glycolysis by dephosphorylating PKM2 in gastric cancer
di: Peiyun Wang, et al.
Pubblicazione: (2024)

Interplay of IL‐17A/IL‐17RA signaling with microbial homeostasis in systemic anti‐tumoral responses
di: Shi‐jun He, et al.
Pubblicazione: (2024)

Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets
di: Xiaodie Liu, et al.
Pubblicazione: (2026)

Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets
di: Qianying Ouyang, et al.
Pubblicazione: (2026)

Inducing disulfidptosis in tumors:potential pathways and significance
di: Tao Mi, et al.
Pubblicazione: (2024)

Nanoparticle‐encapsuled celastrol‐Fe(III): “Single‐edged sword” for tumor therapy featuring microenvironment‐dependent toxicity
di: Yu Liu, et al.
Pubblicazione: (2024)

Targeting the miR‐96‐5p/Cathepsin B Pathway to Alleviate Neuron‐Derived Neuroinflammation in Alzheimer's Disease
di: Kai Zheng, et al.
Pubblicazione: (2025)

Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer
di: Nan Liu, et al.
Pubblicazione: (2025)

Targeted Lung Premetastasis Niche: Mechanisms, Strategies, and Application
di: Chenghao Cao, et al.
Pubblicazione: (2025)

An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
di: Modan Yang, et al.
Pubblicazione: (2024)

Nanoparticle‐Delivered siRNA Targeting NSUN4 Relieves Systemic Lupus Erythematosus through Declining Mitophagy‐Mediated CD8+T Cell Exhaustion
di: Bincheng Ren, et al.
Pubblicazione: (2025)

Comprehensive multi‐omics analysis provides biological insights and therapeutic strategies for small‐cell lung cancer
di: Guo Zhao, et al.
Pubblicazione: (2024)

Axon Initial Segment: Structure, Biological Functions, Diseases, and Therapeutic Targets
di: Dong‐Yan Song, et al.
Pubblicazione: (2026)